This segment focuses on the development, manufacturing, and commercialization of continuous glucose monitoring (CGM) systems. Dexcom's CGM technology provides real-time glucose readings, trend data, and alerts to help individuals manage their diabetes more effectively. Research and development efforts are directed towards improving sensor accuracy, extending sensor life, and enhancing user experience. The CGM systems integrate with digital health platforms and insulin delivery devices to provide comprehensive diabetes management solutions. These systems aim to reduce the burden of diabetes management, improve glycemic control, and enhance the quality of life for people with diabetes. Dexcom's CGM technology has demonstrated significant clinical benefits, including reduced HbA1c levels, decreased risk of hypoglycemia, and improved time-in-range. The company continues to innovate in this area, exploring new sensor technologies, data analytics, and personalized insights to further optimize diabetes management.

This segment encompasses Dexcom's digital health platforms, data analytics capabilities, and connectivity solutions. Dexcom's digital ecosystem includes mobile apps, cloud-based data storage, and APIs that enable integration with third-party devices and platforms. Research and development efforts are focused on developing advanced algorithms, machine learning models, and data visualization tools to provide personalized insights and actionable recommendations to users and healthcare providers. The company leverages real-world data and clinical evidence to improve the effectiveness of its CGM systems and digital health solutions. Dexcom's digital health platform facilitates remote monitoring, telehealth consultations, and data-driven decision-making, empowering individuals to take control of their diabetes management. The company is committed to protecting patient privacy and ensuring data security in its digital health ecosystem. Future opportunities include expanding the use of AI and machine learning to predict glucose trends, personalize treatment plans, and improve patient outcomes.